About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Antimicrobial Agents and Chemotherapy
›
Top Articles
Antimicrobial Agents and Chemotherapy
Pharmacology
,
Biology
,
Microbiology
5.9
(top 2%)
Impact Factor
6.2
(top 2%)
extended IF
293
(top 1%)
H-Index
11.4K
authors
31.2K
papers
1.4M
citations
11K
citing journals
183.6K
citing authors
Most Cited Articles of Antimicrobial Agents and Chemotherapy
Title
Year
Citations
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique
1979
2.1K
In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing
2014
1.9K
A functional classification scheme for beta-lactamases and its correlation with molecular structure
1995
1.8K
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate
1972
1.8K
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India
2009
1.7K
Updated functional classification of beta-lactamases
2010
1.3K
Riddle of biofilm resistance
2001
1.3K
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
2002
1.3K
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
1997
1.3K
Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
2001
1.2K
Peptide antibiotics
1999
1.1K
Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus
2002
1.1K
Bacteriophage therapy
2001
1.1K
Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes
2004
1.1K
The comprehensive antibiotic resistance database
2013
1K
Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality
2005
1K
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
1993
961
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
2005
904
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils
1998
861
Resistance plasmid families in Enterobacteriaceae
2009
844
Global challenge of multidrug-resistant Acinetobacter baumannii
2007
835
Detection of erythromycin-resistant determinants by PCR
1996
808
PCR mapping of integrons reveals several novel combinations of resistance genes
1995
801
Erythromycin resistance by ribosome modification
1995
786
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening
2004
778
previous
2006
2007
2008
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.